Hannah M Sebitloane
Overview
Explore the profile of Hannah M Sebitloane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sebitloane H, Forestier M, Ginindza T, Dhlomo W, Moodley-Govender E, Darragh T, et al.
Cancer Epidemiol Biomarkers Prev
. 2023 Nov;
33(6):779-787.
PMID: 37955560
Background: To report quantitative and qualitative results on cervical cancer human papillomavirus (HPV)-based screening and treatment algorithms, with/out triage with visual inspection after acetic acid (VIA), followed by ablative treatment...
2.
Shabalala E, Sebitloane H
S Afr Med J
. 2017 Oct;
107(7):602-605.
PMID: 29025450
Background: Obstetric haemorrhage (OH) is the leading cause of maternal mortality worldwide, although, indirectly, HIV is also a leading cause of maternal mortality in some settings with a high HIV...
3.
Sebitloane H, Moodley J, Sartorius B
Int J Gynaecol Obstet
. 2017 Jan;
136(2):195-199.
PMID: 28099739
Objective: To explore potential relationships between HIV and highly active anti-retroviral therapy (HAART), and hypertensive disorders of pregnancy (HDP). Methods: A retrospective secondary analysis of maternal-deaths data from the 2011-2013...
4.
Sebitloane H, Moodley D
Eur J Obstet Gynecol Reprod Biol
. 2016 Dec;
210:126-131.
PMID: 28013100
HIV is the leading cause of maternal and neonatal morbidity and mortality in resource constrained countries. Highly active antiretroviral treatment (HAART) initiated in pregnancy has now almost eliminated mother to...
5.